Cite

HARVARD Citation

    Dungan, K. et al. (2016). A 24‐week study to evaluate the efficacy and safety of once‐weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD‐8). Diabetes, obesity & metabolism. 18 (5), pp. 475-482. [Online]. 
  
Back to record